Samantree Medical
The computed 12-month bankruptcy probability of Samantree Medical is 0.3% (very low). The 2025 annual accounts show equity of €39.07M and a net result of €-5.11M. Its solvency ranks better than 74% of 39 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €39.07M |
| Net result | €-5.11M |
| Staff (FTE) | 5.2 |
| Better than sector | 74% |
Mixed profile: strong on solvency, weaker on profitability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 72.4% | 53.4% | |
| Net result | €-5.11M | €16k | |
| Equity | €39.07M | €66k | |
| Gross operating margin | €-3.49M | €45k | |
| Total assets | €53.94M | €119k |
| Fiscal year | 2025 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | €-4.73M |
| Net profit | €-5.11M |
| Cash flow | €-4.79M |
| Staff costs | €1.24M |
| Income taxes | - |
| Dividends | - |
| Total assets | €53.94M |
| Equity | €39.07M |
| Debt | €14.87M |
| of which ≤ 1y | €7.74M |
| of which > 1y | €5.79M |
| Working capital | €13.66M |
| Employees (FTE) | 5.2 |
| 2025 | |
|---|---|
| Current ratio | 2.76 |
| Quick ratio | 2.68 |
| Working capital ratio | 25.3% |
| Solvency | 72.4% |
| Debt / equity | 0.38 |
| Long-term debt ratio | 0.15 |
| Interest coverage | -9.91 |
| Gross margin | - |
| Net margin | - |
| ROA | -9.5% |
| ROE | -13.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (24 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €53.94M |
| Fixed assets | 21/28 | €32.54M |
| Intangible fixed assets | 21 | €23k |
| Tangible fixed assets | 22/27 | €1.05M |
| Financial fixed assets | 28 | €31.46M |
| Current assets | 29/58 | €21.40M |
| Stocks & contracts in progress | 3 | €656k |
| Amounts receivable within one year | 40/41 | €16.02M |
| Cash & bank | 54/58 | €3.96M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €53.94M |
| Equity | 10/15 | €39.07M |
| Contributions / capital | 10/11 | €44.19M |
| Accumulated profits (losses) | 14 | €-5.11M |
| Amounts payable | 17/49 | €14.87M |
| Amounts payable after one year | 17 | €5.79M |
| Amounts payable within one year | 42/48 | €7.74M |
| Trade debts payable within one year | 44 | €1.80M |
| Income statement | ||
| Gross operating margin | 9900 | €-3.49M |
| Operating result | 9901 | €-5.06M |
| Financial income | 75 | €423k |
| Financial charges | 65 | €477k |
| Result before taxes | 9903 | €-5.11M |
| Net result for the period | 9904 | €-5.11M |
| Result to be appropriated | 9905 | €-5.11M |
-
Current24-03-2025 → present
-
Current11-07-2024 → present
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| PricewaterhouseCoopers Reviseurs d'EntreprisesCurrent Company auditor · represented by Didier Delanoye |
- | 28-11-2025 → present |
| NACE primary | Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur(26600) |
| Legal form | Public limited company(014) |
| Incorporation | 23-06-2024 |
| Status | Active |
| Postal code | 4340 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62006B0520/00G002 | Wallonia | 6.6 ha | - | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 9 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
30-04-2026 Capital increase of €28,024.18 to €384,730.80
- €356.706,62 → €384.730,80
- Inbreng in geld · Apport en numéraire
- 4 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": 8529.03,
"share_form": "nominal",
"share_class": "Ordinaires",
"n_new_shares": 37083,
"with_new_shares": true,
"nominal_value_eur": 0.01,
"issue_price_per_share_eur": 0.23
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Henry Charlton",
"share_class": "Pr\u00E9f\u00E9rentielles de Classe B",
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 251709,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": 312119.16,
"share_form": "nominal",
"share_class": "Pr\u00E9f\u00E9rentielles de Classe B",
"n_new_shares": 251709,
"with_new_shares": true,
"nominal_value_eur": 0.01,
"issue_price_per_share_eur": 1.24
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 384730.8,
"delta_eur": 28024.18,
"before_eur": 356706.62,
"share_emission": {
"agio_eur": 3446974.14,
"share_form": "nominal",
"share_class": "Privil\u00E9gi\u00E9es de Classe B",
"n_new_shares": 2802418,
"with_new_shares": true,
"nominal_value_eur": 0.01,
"issue_price_per_share_eur": 1.24
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 28024.18,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 387247.89,
"delta_eur": 2517.09,
"before_eur": 384730.8,
"share_emission": {
"agio_eur": 312119.16,
"share_form": "nominal",
"share_class": "Privil\u00E9gi\u00E9es de Classe B",
"n_new_shares": 251709,
"with_new_shares": true,
"nominal_value_eur": 0.01,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2026-04-30",
"filing_date": "2026-04-28",
"act_kind_objet": "Objet de l\u0027acte : CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2026-04-22",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": "0429.501.944",
"firm_name": "PricewaterhouseCoopers Reviseurs d\u2019Entreprises",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Didier Delanoye"
},
"subject_company": {
"kbo": "1010.646.067",
"name_full": "Samantree Medical",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition du proc\u00E8s-verbal",
"les listes de pr\u00E9sences",
"treize procurations",
"le texte coordonn\u00E9 des statuts",
"le rapport de l\u2019organe d\u2019administration",
"le rapport du commissaire \u00E9valuant",
"le rapport de l\u2019organe d\u2019administration",
"le rapport du commissaire"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 10037083,
"class_name": "Actions Ordinaires",
"capital_share_eur": 100370.83,
"voting_rights_per_share": 1.0
},
{
"n_shares": 10519426,
"class_name": "Actions Privil\u00E9gi\u00E9es de Classe A",
"capital_share_eur": 105194.26,
"voting_rights_per_share": 1.0
},
{
"n_shares": 18168280,
"class_name": "Actions Privil\u00E9gi\u00E9es de Classe B",
"capital_share_eur": 181682.8,
"voting_rights_per_share": 1.0
}
]
}02-12-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-11-28",
"legal_form_change": false
},
"bedrijfsrevisor": {
"quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer \u00E0 la fonction de commissaire de la Soci\u00E9t\u00E9, la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB PwC Reviseurs d\u2019Entreprises \u00BB, ayant son si\u00E8ge \u00E0 1831 Diegem, Culliganlaan 5, et titulaire du num\u00E9ro d\u2019entreprise 0429.501.944, repr\u00E9sent\u00E9e de mani\u00E8re permanente par Monsieur Didier Delanoye, r\u00E9viseur d\u0027entreprises",
"firm_kbo": "0429.501.944",
"firm_name": "PwC Reviseurs d\u2019Entreprises",
"ibr_number": null,
"individual_name": "Didier Delanoye"
},
"subject_company": {
"kbo": "1010.646.067",
"name_full": "SAMANTREE MEDICAL, EN ABREGE : STMBE",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}22-07-2025 Capital increase of €44,331.72 to €356,335.79
- €312.004,07 → €356.335,79
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 4430120.72,
"currency": "EUR",
"after_eur": 356335.79,
"delta_eur": 44331.72,
"before_eur": 312004.07,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-07-04",
"evidence_quote": "Augmentation effective du capital de la Soci\u00E9t\u00E9 par suite d\u0027un apport en num\u00E9raire \u00E0 concurrence de maximum 4.430.120,72 EUR... Le capital de la Soci\u00E9t\u00E9 sera d\u00E8s lors augment\u00E9 \u00E0 concurrence du capital effectivement souscrit... Le capital s\u2019\u00E9l\u00E8ve \u00E0 trois cent cinquante-six mille trois cent trente-cinq euros et septante-neuf cents (356.335,79 EUR).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1010.646.067",
"name_full": "SAMANTREE MEDICAL, EN ABREGE : STMBE",
"legal_form": "SA"
}
}01-04-2025 Capital increase of €22,681.46 to €320,609.01
- €297.927,55 → €320.609,01
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 22681.46,
"currency": "EUR",
"after_eur": 320609.01,
"delta_eur": 22681.46,
"before_eur": 297927.55,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-03-24",
"evidence_quote": "Augmentation effective du capital de la Soci\u00E9t\u00E9 par suite d\u0027un apport en num\u00E9raire \u00E0 concurrence de maximum 2.812.501,04 EUR, en contrepartie duquel seront \u00E9mises maximum 2.268.146 Actions Privil\u00E9gi\u00E9es de Classe B ... ces 2.268.146 Actions Privil\u00E9gi\u00E9es de Classe B seront souscrites en num\u00E9raire \u00E0 un prix de souscription de 1,24 EUR/action, compos\u00E9 d\u2019une valeur nominale de 0,01 EUR/action, soit pour un montant total de 22.681,46 EUR",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1010.646.067",
"name_full": "SAMANTREE MEDICAL, EN ABREGE : STMBE",
"legal_form": "SA"
}
}15-01-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-12-30",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "1010.646.067",
"name_full": "SAMANTREE MEDICAL, EN ABREGE : STMBE",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}01-10-2024 Registered office moved from Rosières to Awans
- Rue des Bergères 2, 1331 Rosières → Rue de Bruxelles 174, 4340 Awans
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Awans",
"region": "Waals",
"street": "Rue de Bruxelles",
"country": "BE",
"postcode": "4340",
"box_number": null,
"street_number": "174"
},
"old_address": {
"city": "Rosi\u00E8res",
"region": "Waals",
"street": "Rue des Berg\u00E8res",
"country": "BE",
"postcode": "1331",
"box_number": null,
"street_number": "2"
},
"effective_date": "2024-09-01",
"evidence_quote": "tous les membres du Conseil d\u0027Administration d\u00E9cident de transf\u00E9rer, \u00E0 compter du 1er septembre 2024, le si\u00E8ge de la Soci\u00E9t\u00E9 de la Rue des Berg\u00E8res, 2 \u00E0 1331 Rosi\u00E8res (Belgique) vers le \u00ABE40 Business Park\u00BB, Rue de Bruxelles, 174 \u00E0 4340 Awans (Belgique)."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1010.646.067",
"name_full": "SAMANTREE MEDICAL, EN ABREGE : STMBE",
"legal_form": "SA"
}
}31-07-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-07-11",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "1010.646.067",
"name_full": "SAMANTREE MEDICAL, EN ABREGE : STMBE",
"legal_form": "SA"
},
"signature_regime": "joint_two",
"special_mandates": [
{
"quote": "\u00E0 Ma\u00EEtre St\u00E9phane ROBYNS de SCHNEIDAUER, avocat, dont le cabinet d\u2019avocats ACOLEGAL est \u00E9tabli Boulevard Brand Whitlock, 24A \u00E0 1200 Bruxelles (Belgique)... pour accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s relatives \u00E0 l\u2019ex\u00E9cution des formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es lors de la pr\u00E9sente assembl\u00E9e et, en particulier, la publication de ces r\u00E9solutions aux Annexes au Moniteur belge et la mise \u00E0 jour de l\u2019inscription de la Soci\u00E9t\u00E9 au Registre des Personnes Morales",
"holder_kbo": null,
"holder_name": "Ma\u00EEtre St\u00E9phane ROBYNS de SCHNEIDAUER",
"scope_categories": [
"publication",
"KBO",
"filing"
],
"with_substitution": true
},
{
"quote": "\u00E0 tout autre notaire et/ou collaborateur de \u0022Berquin Notaires\u0022 SRL... pour accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s relatives \u00E0 l\u2019ex\u00E9cution des formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es lors de la pr\u00E9sente assembl\u00E9e et, en particulier, la publication de ces r\u00E9solutions aux Annexes au Moniteur belge et la mise \u00E0 jour de l\u2019inscription de la Soci\u00E9t\u00E9 au Registre des Personnes Morales",
"holder_kbo": null,
"holder_name": "Berquin Notaires SRL",
"scope_categories": [
"publication",
"KBO",
"filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": [
{
"name": "Olivier Delporte",
"quote": "ODMC SRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Olivier Delporte, Administrateur et CEO.",
"excluded_powers": null
}
]
}
}26-06-2024 Incorporation of a new SNC
Technical details
{
"kind": "oprichting",
"seat": "1331 Rosi\u00E8res, Rue des Berg\u00E8res 2",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": null,
"name": "ODMC SRL"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Actions de Fondateurs",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "ODMC SRL",
"contribution_type": "cash",
"amount_paid_in_eur": 55350.0,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 5535000,
"amount_subscribed_eur": 55350.0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "B\u0026O Associates SRL"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Actions de Fondateurs",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "B\u0026O Associates SRL",
"contribution_type": "cash",
"amount_paid_in_eur": 6150.0,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 615000,
"amount_subscribed_eur": 6150.0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 61500.0,
"subject_company": {
"kbo": "1010.646.067",
"name_full": "Samantree Medical",
"legal_form": "SNC"
},
"initial_directors": [],
"incorporation_date": "2024-06-20",
"post_incorporation_mandates": []
}| Legal nameFR | Samantree Medical |
| AbbreviationFR | STMBE |